Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.081 USD | +2.79% | +12.55% | -60.00% |
Mar. 26 | Transcript : NovaBay Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 26, 2024 | |
Mar. 26 | NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
- Stock Market
- Equities
- NBY Stock
- News NovaBay Pharmaceuticals
- NovaBay to Commercialize BioStem's Amniotic Tissue Allograft